Taste Masking
Developing novel pharmaceutical technology that provides for outstanding taste masking for a broad range of pharmaceuticals including major drug categories such as NSAIDS and statins.
News
01 March 2010
Board changes
The Company announces that Marcelo Bravo, Non Executive Chairman of Oxford Nutrascience is to become Executive Chairman with immediate effect. Marcelo spent 16 years in R&D with The Procter & Gamble Company and subsequently spent three years in corporate development with Boots (now Boots Alliance) and is also an experienced entrepreneur.
The Company intends to appoint an additional Non-Executive Director and an announcement will be made as and when appropriate.
Nigel Theobald, Chief Executive, Oxford Nutrascience Group Plc commented:
"The Company is looking to work with a number of the major brand owners in the Over the Counter and prescription pharmaceutical sectors. Marcelo has considerable experience of these companies and we look forward to benefiting from his increased contribution."
For further information:
The Admission Document in relation to the Company's Admission is available on the Company's website at www.oxfordnutrascience.com
| Oxford Nutrascience Group Plc | +44 1865 854874 |
| Nigel Theobald (Chief Executive Officer) | |
| Mark Way (Investor and Media relations) | +44 7786 116991 |
| ZAI Corporate Finance (Nominated Adviser) | +44 20 7060 2220 |
| David Newton |
About Oxford Nutrascience Group Plc
- Oxford Nutrascience is a UK consumer healthcare company that develops chewy confectionery, chewable tablets and liquid suspensions to allow medicines and vitamin supplements to be taken in a more pleasant and convenient way.
- Oxford Nutrascience has developed technology for the use of prebiotic soluble fibres in medicine delivery systems that disperse and solubilise medicines, improve taste and mouth feel, simplify processing and eliminate additives, incorporate prebiotic health benefits.
- Chews: Oxford Nutrascience currently produces Ellactiva®, a calcium chewy supplement sold in the UK and in the Middle East, and plans to launch new chews to complement this existing product.
- Chewable tablets and liquid suspensions: The target market for Oxford Nutrasciences' Chewitabs™ and liquid suspension delivery systems are over-the-counter ("OTC") pain relieving drugs, indigestion preparations and cough and cold medicines.
- Oxford Nutrascience's medicine development work is currently focused on ibuprofen suspension and chewable allergy tablets incorporating loratadine.